Document is current

Any future updates will be listed below

Lidocaine inhibits the lung cancer progression through decreasing the HIST1H2BL levels via SIRT5 mediated succinylation

Crossref DOI link: https://doi.org/10.1038/s41598-024-73966-9

Published Online: 2024-10-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark